Latest Regulatory News

Spark New Zealand is selling 75% of its data centre business to Pacific Equity Partners for up to $705 million, aiming to accelerate capacity expansion amid rising cloud and AI demand.

Seven West Media reports a robust 33% rise in underlying net profit, driven by a 26% jump in 7plus digital revenue, even as traditional TV advertising revenue declines by 4%.

Envirosuite Limited’s shares will be suspended from ASX trading following Federal Court approval of its acquisition by Ideagen EVS BidCo Pty Limited. This marks a pivotal step in the environmental software company’s transition under new ownership.

GTN Limited has finalised a $43.85 million capital return, distributing $0.23 per share to shareholders. The company awaits an Australian Tax Office ruling to clarify tax implications for investors.

Imagion Biosystems has completed the first tranche of its $3.5 million capital raising, issuing 45 million new shares to strengthen its financial position ahead of a key shareholder vote.

Peak Rare Earths Limited shareholders are set to vote on a scheme of arrangement proposing acquisition by Shenghe Resources (Singapore) Pte. Ltd., valuing Peak at approximately A$158 million and offering a substantial premium over recent trading prices.

Envirosuite Limited’s acquisition by Ideagen Limited has received Federal Court approval, making the scheme legally effective and triggering imminent suspension of Envirosuite shares on the ASX.

Tuas Limited, through its subsidiary Simba Telecom, has announced a transformative acquisition of M1 Limited’s non-ICT businesses for S$1.43 billion, accompanied by a substantial equity raising and debt financing plan.

Tuas Limited is poised to reshape Singapore’s telecom landscape by acquiring M1 Limited for S$1.43 billion, backed by a substantial equity raise and bank debt financing. The deal promises enhanced network capabilities and operational synergies, pending regulatory approval.

Island Pharmaceuticals has raised $350,000 through an options exercise by substantial shareholder MWP Partners, reinforcing confidence in its antiviral drug development pipeline.

Reef Casino Trust has received a revised $184.3 million takeover offer from Morris Group, intensifying a competitive bidding process with Iris Cairns Property. Unitholders are advised to hold off on decisions as the Independent Board Committee evaluates the proposals.

Syntara Limited is set to update investors on the clinical progress of its lead drug candidate amsulostat, targeting myelofibrosis, in a webinar scheduled for 11 August 2025. The company highlights recent regulatory milestones and advancing trials.